Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation
- 24 December 2023
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 305, 122452
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The metabolic function of cyclin D3–CDK6 kinase in cancer cell survivalNature, 2017
- Designing Core–Shell Gold and Selenium Nanocomposites for Cancer RadiochemotherapyACS Nano, 2017
- A Sequentially Triggered Nanosystem for Precise Drug Delivery and Simultaneous Inhibition of Cancer Growth, Migration, and InvasionAdvanced Functional Materials, 2016
- Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductaseJournal of Materials Chemistry B, 2015
- The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrenceNature Reviews Cancer, 2015
- Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathwaysBiomaterials, 2015
- Contribution of p53 to MetastasisCancer Discovery, 2014
- Synergistic Induction of Apoptosis by Methylseleninic Acid and Cisplatin, The Role of ROS-ERK/AKT-p53 PathwayMolecular Pharmaceutics, 2014
- Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathwayFree Radical Biology and Medicine, 2013
- Tumor Microenvironment and Myeloid-Derived Suppressor CellsCancer Microenvironment, 2012